Researchers have developed a new antimalarial drug candidate designed to address the growing challenge of drug resistance and ...

KYOTO, Japan — The antimalarial drug mefloquine may prove to be an effective treatment for progressive multifocal leukoencephalopathy (PML) in patients not infected with HIV, a small, preliminary ...

Malaria represents one of the most serious threats to human health worldwide, and preventing and curing this parasitic disease still depends predominantly on the administration of a small number of ...

Researchers have developed a new antimalarial drug candidate designed to address the growing challenge of drug resistance and potentially reduce ...

The antimalarial drug mefloquine could help treat genetic diseases such as cystic fibrosis, Duchenne muscular dystrophy, as well as some cancers. In these diseases, a mutation in the genetic code ...

Aminopeptidases constitute a diverse family of enzymes responsible for cleaving N‐terminal amino acids from peptide substrates, a process central to protein turnover and nutrient acquisition in ...

GENEVA (AP) — Switzerland's medical products authority has granted the first approval for a malaria medicine designed for small infants, touted as an advance against a disease that takes hundreds of ...

Australian researchers have worked with global phamarceutical company MSD to co-develop a new antimalarial drug candidate ...